These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 32850884)

  • 1. Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD.
    Jiang X; Zheng J; Zhang S; Wang B; Wu C; Guo X
    Front Med (Lausanne); 2020; 7():361. PubMed ID: 32850884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Biological Clock: A Pivotal Hub in Non-alcoholic Fatty Liver Disease Pathogenesis.
    Mazzoccoli G; De Cosmo S; Mazza T
    Front Physiol; 2018; 9():193. PubMed ID: 29662454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral and Gut Microbial Dysbiosis and Non-alcoholic Fatty Liver Disease: The Central Role of
    Wang T; Ishikawa T; Sasaki M; Chiba T
    Front Med (Lausanne); 2022; 9():822190. PubMed ID: 35308549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota, fatty liver disease, and hepatocellular carcinoma.
    Chu H; Williams B; Schnabl B
    Liver Res; 2018 Mar; 2(1):43-51. PubMed ID: 30416839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity, fatty liver disease and intestinal microbiota.
    Arslan N
    World J Gastroenterol; 2014 Nov; 20(44):16452-63. PubMed ID: 25469013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Unhealthy Nutrition and Circadian Dysregulation in Pathophysiology of NAFLD.
    Guo X; Zheng J; Zhang S; Jiang X; Chen T; Yu J; Wang S; Ma X; Wu C
    Front Clin Diabetes Healthc; 2021; 2():691828. PubMed ID: 36994336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of the gut microbiota to the regulation of host metabolism and energy balance: a focus on the gut-liver axis.
    Delzenne NM; Knudsen C; Beaumont M; Rodriguez J; Neyrinck AM; Bindels LB
    Proc Nutr Soc; 2019 Aug; 78(3):319-328. PubMed ID: 30628563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?
    Xie C; Halegoua-DeMarzio D
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31752378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver and the gut microbiota.
    Bashiardes S; Shapiro H; Rozin S; Shibolet O; Elinav E
    Mol Metab; 2016 Sep; 5(9):782-94. PubMed ID: 27617201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease.
    Augustyn M; Grys I; Kukla M
    Clin Exp Hepatol; 2019 Mar; 5(1):1-10. PubMed ID: 30915401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease.
    Wieland A; Frank DN; Harnke B; Bambha K
    Aliment Pharmacol Ther; 2015 Nov; 42(9):1051-63. PubMed ID: 26304302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Dysfunction and Non-alcoholic Fatty Liver Disease.
    Grabherr F; Grander C; Effenberger M; Adolph TE; Tilg H
    Front Endocrinol (Lausanne); 2019; 10():611. PubMed ID: 31555219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Microbiota and Host Reaction in Liver Diseases.
    Fukui H
    Microorganisms; 2015 Oct; 3(4):759-91. PubMed ID: 27682116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D Signaling through Induction of Paneth Cell Defensins Maintains Gut Microbiota and Improves Metabolic Disorders and Hepatic Steatosis in Animal Models.
    Su D; Nie Y; Zhu A; Chen Z; Wu P; Zhang L; Luo M; Sun Q; Cai L; Lai Y; Xiao Z; Duan Z; Zheng S; Wu G; Hu R; Tsukamoto H; Lugea A; Liu Z; Pandol SJ; Han YP
    Front Physiol; 2016; 7():498. PubMed ID: 27895587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Food and Gut Microbiota-Derived Metabolites in Nonalcoholic Fatty Liver Disease.
    Jeong MK; Min BH; Choi YR; Hyun JY; Park HJ; Eom JA; Won SM; Jeong JJ; Oh KK; Gupta H; Ganesan R; Sharma SP; Yoon SJ; Choi MR; Kim DJ; Suk KT
    Foods; 2022 Sep; 11(17):. PubMed ID: 36076888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.
    Neuman MG; French SW; Zakhari S; Malnick S; Seitz HK; Cohen LB; Salaspuro M; Voinea-Griffin A; Barasch A; Kirpich IA; Thomes PG; Schrum LW; Donohue TM; Kharbanda KK; Cruz M; Opris M
    Exp Mol Pathol; 2017 Feb; 102(1):162-180. PubMed ID: 28077318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiome and nonalcoholic fatty liver diseases.
    Zhu L; Baker RD; Baker SS
    Pediatr Res; 2015 Jan; 77(1-2):245-51. PubMed ID: 25310763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Green Plant Pigment, Chlorophyllin, Ameliorates Non-alcoholic Fatty Liver Diseases (NAFLDs) Through Modulating Gut Microbiome in Mice.
    Yang Y; Jiang X; Pandol SJ; Han YP; Zheng X
    Front Physiol; 2021; 12():739174. PubMed ID: 34764881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Dysbiosis and Increased Intestinal Permeability Drive microRNAs, NLRP-3 Inflammasome and Liver Fibrosis in a Nutritional Model of Non-Alcoholic Steatohepatitis in Adult Male Sprague Dawley Rats.
    Longo L; Tonin Ferrari J; Rampelotto PH; Hirata Dellavia G; Pasqualotto A; P Oliveira C; Thadeu Schmidt Cerski C; Reverbel da Silveira T; Uribe-Cruz C; Álvares-da-Silva MR
    Clin Exp Gastroenterol; 2020; 13():351-368. PubMed ID: 32982365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.